EUVIMEDScopri EUVIMED
Crossref

Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: A new tracer for cancer detection

H Fukuda, T Matsuzawa, Y Abe, S Endo, K Yamada, K Kubota, J Hatazawa, T Sato, M Ito, T Takahashi, R Iwata, T Ido

European Journal of Nuclear Medicine · 1982-07 · 7 (7) · 294-297

DOI: 10.1007/bf00253423 ↗

At a glance

Journal article in European Journal of Nuclear Medicine, published online on 1982-07-01. Written by H Fukuda and 11 co-authors. Major MEDLINE topics: Deoxy Sugars, Deoxyglucose, Fluorine, Radioisotopes. Cited 77 times so far (Crossref); 12 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) and 18F-2-fluoro-2-deoxy-D-mannose (18F-FDM) were tested as tumor diagnostic agents in a transplantable rat tumor and rabbit tumors. Tissue distribution studies in rats showed high tumor uptakes of both radiopharmaceuticals. The tumor uptake reached 2.65 +/- 0.61% dose 18 dose F-FDG/g and 2.65 +/- 0.81% dose 18F-FDM/g at 60 min and remained relatively constant until 120 min. Blood clearance both 18F-FDG and 18F-FDM was very rapid and tumor-to-blood ratios reached 22.1 and 29.4 at 60 min, respectively. Tumor-to-tissue ratios of both radiopharmaceuticals were very high in most organs, especially in the liver, kidney, and pancreas. Positron emission tomography (PET) of rabbit tumor with 18F-FDM clearly delineated the main tumor, central necrosis, and lymph node metastases. These data suggested that 18F-FDM, which is a by-product of 18F-FDG synthesis was also an excellent cancer diagnostic agent as well as 18F-FDG. This is not only a new feature of 18F-FDM, but also an economical improvement on cancer diagnosis by PET.

Subjects

MeSH terms (MEDLINE)

Deoxy SugarsDeoxyglucoseFluorineRadioisotopesAnimalsAutoradiographyCarcinoma, Squamous CellFluorodeoxyglucose F18Liver Neoplasms, ExperimentalMaleNeoplasm TransplantationRabbitsRatsRhamnoseTissue DistributionTomography, Emission-Computed

Substances

Deoxy SugarsRadioisotopesFluorodeoxyglucose F18Fluorine2-deoxy-2-fluoromannoseDeoxyglucoseRhamnose

Cite

APA

Fukuda, H., Matsuzawa, T., Abe, Y., Endo, S., Yamada, K., Kubota, K., Hatazawa, J., Sato, T., Ito, M., Takahashi, T., Iwata, R., & Ido, T. (1982). Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: A new tracer for cancer detection. European Journal of Nuclear Medicine, 7(7), 294-297. https://doi.org/10.1007/bf00253423

Vancouver

Fukuda H, Matsuzawa T, Abe Y, Endo S, Yamada K, Kubota K, et al. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: A new tracer for cancer detection. European Journal of Nuclear Medicine. 1982;7(7):294-297. doi:10.1007/bf00253423

BibTeX
@article{Fukuda1982,
  author = {Fukuda, H and Matsuzawa, T and Abe, Y and Endo, S and Yamada, K and Kubota, K and Hatazawa, J and Sato, T and Ito, M and Takahashi, T and Iwata, R and Ido, T},
  title = {Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: A new tracer for cancer detection},
  journal = {European Journal of Nuclear Medicine},
  year = {1982},
  volume = {7},
  number = {7},
  pages = {294--297},
  doi = {10.1007/bf00253423}
}
Start for free →